Expanded Use of TIMI Risk Score for CV Event Prediction in Diabetes
The TIMI Risk Score provides a practical risk assessment tool for patients with type 2 diabetes.
For overweight African Americans with vitamin D deficiency, arterial stiffness is improved by vitamin D3 supplementation in a dose-response manner.
For patients with type 2 diabetes, all weight categories show increased long-term mortality.
Glucagon-like peptide-1 receptor agonists can reduce major adverse cardiovascular events in patients with type 2 diabetes.